Please use this identifier to cite or link to this item:
|Title:||Simvastatin reverses the downregulation of dopamine D1 and D2 receptor expression in the prefrontal cortex of 6-hydroxydopamine-induced Parkinsonian rats||Authors:||Wang, Q.
Dopamine D1and D2receptors
Parkinson's disease (PD)
Simvastatin, hydroxymethylglutaryl-coenzyme A reductase inhibitor
|Issue Date:||2005||Citation:||Wang, Q., McLachlan, C., Wong, P.T.-H., Wang, P.H. (2005). Simvastatin reverses the downregulation of dopamine D1 and D2 receptor expression in the prefrontal cortex of 6-hydroxydopamine-induced Parkinsonian rats. Brain Research 1045 (1-2) : 229-233. ScholarBank@NUS Repository. https://doi.org/10.1016/j.brainres.2005.03.016||Abstract:||Sprague-Dawley rats with unilateral lesion of the medial forebrain bundle by 6-hydroxydopamine showed marked decrease in the expression of dopamine D 1 and D2 receptors in the prefrontal cortex. Simvastatin (10 mg/kg/day for 4 weeks) restored receptor expression to control levels. Given the association of dopaminergic dysfunction in the prefrontal cortex and cognitive deficits in Parkinson's disease, these findings may have implication in the treatment of cognitive decline in advanced Parkinson's disease. © 2005 Elsevier B.V. All rights reserved.||Source Title:||Brain Research||URI:||http://scholarbank.nus.edu.sg/handle/10635/32248||ISSN:||00068993||DOI:||10.1016/j.brainres.2005.03.016|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Aug 15, 2020
WEB OF SCIENCETM
checked on Aug 7, 2020
checked on Aug 4, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.